Microbot Medical Inc
CY9D
Company Profile
Business description
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot’s LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.
Contact
175 Derby Street
Bld 27
HinghamMA02043
USAT: +1 781 875-3605
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2025
Employees
22
Stocks News & Analysis
stocks
Have the 3 biggest losers of the ASX 200 fallen too far?
Finding value in some of the ASX’s worst recent performers.
stocks
Rethinking the way we invest in Aussie tech
Investing in Tech companies has many caveats from traditional investing. Let’s dive into how you can gauge the true profitability of a tech company.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,866.50 | 56.50 | -0.63% |
| CAC 40 | 8,122.71 | 23.24 | 0.29% |
| DAX 40 | 23,836.79 | 68.83 | 0.29% |
| Dow JONES (US) | 47,716.42 | 289.30 | 0.61% |
| FTSE 100 | 9,720.51 | 26.58 | 0.27% |
| HKSE | 25,924.95 | 66.06 | 0.26% |
| NASDAQ | 23,365.69 | 151.00 | 0.65% |
| Nikkei 225 | 49,236.45 | 1,017.46 | -2.02% |
| NZX 50 Index | 13,448.49 | 40.66 | -0.30% |
| S&P 500 | 6,849.09 | 36.48 | 0.54% |
| S&P/ASX 200 | 8,565.20 | 48.90 | -0.57% |
| SSE Composite Index | 3,900.03 | 11.44 | 0.29% |